Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Archives of Internal Medicine

• Publication date

  2007-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.167.15.1648PMID 17698688PMCID PMC2424189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex Differences in Pharmacokinetics and Pharmacodynamics

  2009cited by this paper
• Healthcare Resource Utilization and Costs Associated with Recurrent Episodes of Atrial Fibrillation: The FRACTAL Registry

  2007cited by this paper
• Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.

  2006cited by this paper
• Is rate control or rhythm control preferable in patients with atrial fibrillation? An argument for maintenance of sinus rhythm in patients with atrial fibrillation.

  2005cited by this paper
• Amiodarone versus sotalol for atrial fibrillation.

  2005cited by this paper
• Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.

  2005cited by this paper
• Bmc Medical Research Methodology Open Access Comparison of Nested Case-control and Survival Analysis Methodologies for Analysis of Time-dependent Exposure

  2005cited by this paper
• An Argument for Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

  2005cited by this paper
• Is There a Role for Maintaining Sinus Rhythm in Patients with Atrial Fibrillation?

  2004cited by this paper
• Use of Population Modeling to Define Rational Monitoring of Amiodarone Hepatic Effects

  2004cited by this paper
• Effect of Amiodarone Dose on the Risk of Permanent Pacemaker Insertion

  2004cited by this paper
• Sex differences in pharmacokinetics and pharmacodynamics.

  2004cited by this paper
• Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.

  2004cited by this paper
• Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations.

  2004cited by this paper
• Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

  2003cited by this paper
• Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.

  2003cited by this paper
• A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

  2003cited by this paper
• Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction.

  2003influential reference
• Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.

  2003cited by this paper
• Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis.

  2003cited by this paper
• Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.

  2003cited by this paper
• Circadian Profile of Cardiac Autonomic Nervous Modulation in Healthy Subjects:

  2003cited by this paper
• Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase.

  2002cited by this paper
• How Important Are Gender Differences in Pharmacokinetics?

  2002cited by this paper
• Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France

  2002cited by this paper
• A comparison of rate control and rhythm control in patients with atrial fibrillation.

  2002cited by this paper
• A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

  2002cited by this paper
• Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications.

  2001cited by this paper
• Gender-Based Differences in the Toxicity of Pharmaceuticals—The Food and Drug Administration's Perspective

  2001cited by this paper
• Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

  2000cited by this paper
• Amiodarone to Prevent Recurrence of Atrial Fibrillation

  2000cited by this paper
• Faster clearance of sustained release verapamil in men versus women: Continuing observations on sex‐specific differences after oral administration of verapamil

  2000cited by this paper
• Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

  2000cited by this paper
• Gender‐related differences in pharmacokinetics and their clinical significance

  1999cited by this paper
• Time-dependent covariates in the Cox proportional-hazards regression model.

  1999cited by this paper
• Evidence-based analysis of amiodarone efficacy and safety.

  1999cited by this paper
• Gender‐related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers

  1999cited by this paper
• Gender Differences in Adverse Drug Reactions

  1998cited by this paper
• Risk of Initiating Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients Admitted to a University Hospital

  1997influential reference
• Cellular electropharmacology of amiodarone.

  1997cited by this paper
• Adverse effects of low dose amiodarone: a meta-analysis.

  1997cited by this paper
• Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect.

  1996cited by this paper
• Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.

  1993cited by this paper
• Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans.

  1991cited by this paper
• Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.

  1990cited by this paper
• Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.

  1987cited by this paper

• Mechanistic Insights into Sex Differences in Atrial Electrophysiology and Arrhythmia Vulnerability through Sex-specific Computational Models

  2025cites this paper
• Mechanistic insights into sex differences in atrial electrophysiology and arrhythmia vulnerability through sex-specific computational models.

  2025cites this paper
• Hormonal Atrial Fibrillation: Pathophysiological Mechanisms That Trigger and Sustain the Arrhythmic Circuits

  2025cites this paper
• Bridging the Gender Gap in Cardiovascular Medicine: Addressing Drug Intolerances and Personalized Care for Women with Angina/Ischemia with Non-Obstructive Coronary Artery Disease

  2024cites this paper
• Sex Differences in Electrophysiology and Calcium Handling in Atrial Health and Fibrillation.

  2024cites this paper
• Small Organic Compounds Mimicking the Effector Domain of Myristoylated Alanine-Rich C-Kinase Substrate Stimulate Female-Specific Neurite Outgrowth

  2023cites this paper
• Sex and Gender Differences in Ventricular Arrhythmias

  2023cites this paper
• Sex Differences in Atrial Fibrillation

  2023cites this paper
• A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications

  2023cites this paper
• A Cross-sectional study to find the prevalence of amiodarone related adverse effects in patients with various cardiovascular disorders in a teaching hospital in Western Area of Saudi Arabia

  2022cites this paper
• Future bradyarrhythmia in patients with hypertrophic cardiomyopathy

  2021cites this paper
• Efficacy of amiodarone in the treatment of ventricular arrhythmias in patients with coronary artery disease in Bangladesh

  2021cites this paper
• Safety and efficacy of antiarrhythmic drugs

  2020cites this paper
• Amiodarone: A Comprehensive Guide for Clinicians

  2020cites this paper
• Anti‐arrhythmic drug therapy in implantable cardioverter‐defibrillator recipients

  2019cites this paper
• Rate- and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.

  2019cites this paper
• Gender Differences in Atrial Fibrillation: Incidence, Mechanistic Basis of the Differences and Treatment Options

  2018cites this paper
• Gender and AF: Differences and Disparities

  2018cites this paper
• Cardiac implantable electrical devices in women

  2018cites this paper
• Effects of Adequate Iodine Supply on the Incidence of Iodine-Induced Thyroid Disorders in Slovenia

  2017cites this paper
• To use or not to use? Amiodarone before heart transplantation

  2017cites this paper
• Arrhythmias in Cardiomyopathy

  2017cites this paper
• Gender-based personalized pharmacotherapy: a systematic review

  2017cites this paper
• Congestive Heart Failure and Cardiac Transplantation

  2017influential citation
• Atrial fibrillation and female sex

  2015cites this paper
• The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada

  2015cites this paper
• Amiodarone for atrial fibrillation: Friend or foe?

  2015cites this paper
• Impact of Sex and Ethnicity on Arrhythmic Risk

  2015cites this paper
• USEFULNESS OF FREE THYROXINE TO FREE TRIIODOTHYRONINE RATIO FOR DIAGNOSTICS OF VARIOUS TYPES OF HYPERTHYROIDISM

  2015cites this paper
• Current approaches to antiarrhythmic therapy in heart failure.

  2014cites this paper
• Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms.

  2014cites this paper
• Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991-2010).

  2013cites this paper
• Atrial Fibrillation Antiarrhythmic Drug Therapy for Atrial Fibrillation

  2012cites this paper
• Sex and gender in adverse drug events, addiction, and placebo.

  2012cites this paper
• Sex and Gender Differences in Cardiovascular Disease

  2012cites this paper
• Chronic heart failure in women. Brief review with a focus on new quality markers in therapy.

  2012cites this paper
• Antiarrhythmic drug therapy for atrial fibrillation.

  2012cites this paper
• The effect of sex/gender on cardiovascular pharmacology.

  2011cites this paper
• Pacing in older people

  2011cites this paper
• Sex-Based Differences in Cardiac Arrhythmias, ICD Utilisation and Cardiac Resynchronisation Therapy

  2011cites this paper
• Sex Bias in Studies Selected for Clinical Guidelines

  2011cites this paper
• Sex differences in arrhythmias

  2010cites this paper
• Chronické srdcové zlyhávanie – zaostrené na ženy

  2009cites this paper
• Chronic heart failure - focused on women

  2009cites this paper
• Sex differences in response to chronic heart failure therapies

  2008cites this paper